FuturHealth review
FuturHealth brings clinical prescribing and nutrition tools together. Before enrolling, distinguish ongoing clinical follow-up from the app’s everyday food and activity features.
The verdict
FuturHealth is a reasonable program to investigate if branded medication and nutrition support matter to you. The deciding care question is how often the prescriber reviews your treatment and how quickly side-effect concerns reach that clinician.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide · Orforglipron
- Form
- Injection · Oral
- Prescription
- Required
- Compounded
- No
FuturHealth combines online weight-management care with access to FDA-approved medication and a nutrition-focused app. The current program page lists Wegovy injection and pill, Zepbound and Foundayo.
Who writes the prescription, and what do they see?
A licensed clinician reviews the intake, discusses the patient’s health and recommends a treatment plan when appropriate. The published medical advisory team helps describe the program’s expertise; it does not identify which clinician will personally treat a new patient.
The care process describes online consultation, medication delivery, ongoing support and progress tracking. The app includes meal tracking and nutrition resources. A fixed appointment frequency and guaranteed response time were not established on the program pages reviewed.
What happens when the dose goes up?
The prescriber should determine the medication and any dose changes. Before a refill, ask how tolerance and response are reviewed, whether a visit is needed and what happens if a slower increase changes the prescription.
What the price includes
The displayed drug offers are introductory: $198 monthly for Foundayo or Wegovy pill, $299 for Wegovy injection and $395 for Zepbound. These are not established standing, medication-inclusive monthly totals. Ask for the ongoing care and drug charges together.
What it claims, and what it cites
The current program describes FDA-approved branded medicines rather than a compounded injection bundle. The choice depends on the licensed clinician’s assessment. Do not assume every listed medicine has the same eligibility criteria, format or cost.
Where it holds up, and where it does not
- Strength: Current program specifies branded medicines
- Strength: Clinical and nutrition support are described
- Strength: App supports tracking between contacts
- Limitation: No universal follow-up cadence established
- Limitation: Introductory figures do not establish ongoing total cost
- Limitation: Medical advisory team is not the assigned prescriber
What the evidence says about this kind of treatment
The assessment above is about FuturHealth. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- Someone considering a branded prescription who wants nutrition tools alongside online clinical care.
- Wrong for
- Someone seeking a known all-in compounded price or guaranteed access to a particular brand.
The evidence behind what FuturHealth prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
- What Is Orforglipron? A Daily GLP-1 Tablet That Is Not a Peptide
A small-molecule daily tablet, not a peptide. Over 72 weeks in 3,127 adults, weight fell 11.2% on the top dose against 2.1% on placebo. No trial has compared it against an injection.
How FuturHealth compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: Try AgelessTRYM HealthTryoziTuyo HealthTyde WellnessUR Meds
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Does FuturHealth currently describe compounded medication?
- The program pages reviewed describe FDA-approved branded options. Confirm the exact drug on the proposed treatment plan.
- Are the results and testimonials a personal prediction?
- No. Trial results and individual testimonials do not establish what a particular patient will lose or how quickly.
Sources for this review
Provider information checked . Terms can change.